Abstract

Life cycle limitation hampers the production of high amounts of primary human mesenchymal stroma-/stem-like cells (MSC) and limits cell source reproducibility for clinical applications. The characterization of permanently growing MSC544 revealed some differentiation capacity and the simultaneous presence of known MSC markers CD73, CD90, and CD105 even after continuous long-term culture for more than one year and 32 passages. The expression of CD13, CD29, CD44, and CD166 were identified as further surface proteins, all of which were also simultaneously detectable in various other types of primary MSC populations derived from the umbilical cord, bone marrow, and placenta suggesting MSC-like properties in the cell line. Proliferating steady state MSC544 exhibited immune-modulatory activity similar to a subpopulation of long-term growth-inhibited MSC544 after 189d of continuous culture in confluency. This confluent connective cell layer with fibroblast-like morphology can spontaneously contract and the generated space is subsequently occupied by new cells with regained proliferative capacity. Accordingly, the confluent and senescence-associated beta-galactosidase-positive MSC544 culture with about 95% G0/G1 growth-arrest resumed re-entry into the proliferative cell cycle within 3d after sub-confluent culture. The MSC544 cells remained viable during confluency and throughout this transition which was accompanied by marked changes in the release of proteins. Thus, expression of proliferation-associated genes was down-modulated in confluent MSC544 and re-expressed following sub-confluent conditions whilst telomerase (hTERT) transcripts remained detectable at similar levels in both, confluent growth-arrested and proliferating MSC544. Together with the capability of connective cell layer formation for potential therapeutic approaches, MSC544 provide a long term reproducible human cell source with constant properties.

Highlights

  • Tissue-derived primary mesenchymal stroma-/stem-like cells (MSC) represent a heterogeneous cell mixture comprised of multiple types of distinct stroma and stem-like cells rather than a uniform population

  • The typical cell surface molecules CD73, CD90, and CD105 as minimal characteristics for the identification of MSC were detectable in primary MSC from the umbilical cord, bone marrow, and placenta at low passages (P0 to P4), whereby similar expression levels in MSC544 confirmed MSC-like properties in a high passage of P22 [21]

  • The panel of surface molecules was enlarged by CD13, CD29, CD44 and CD166 which is in line with previous characterizations of BM-MSC and AD-MSC, except for Stro-1 [22]

Read more

Summary

Introduction

Tissue-derived primary mesenchymal stroma-/stem-like cells (MSC) represent a heterogeneous cell mixture comprised of multiple types of distinct stroma and stem-like cells rather than a uniform population. MSC exhibit therapeutic potential associated with multiple and controversially discussed functions. These include early developmental tasks, and later on in adult human tissues, distinct repair and regenerative activities, involvement in neovascularization, immune-modulatory capabilities, paracrine effects, antimicrobial functions, tumor-inhibitory and tumor-promoting properties, and cell fusion, among others. MSC are attributed with different nomenclatures like mesenchymal stromal or mesenchymal stem(-like) or medicinal signaling cells [1,2]. These often-not-precisely but interchangeably used terms underscore the still limited understanding about characteristics and the biological role of MSC [3]. Human MSC can be derived from neonatal birth-associated tissues such as the placenta (PL-MSC), umbilical cord (UC-MSC), and amniotic membrane (AM-MSC), and may exhibit superior in vitro growth potential and regenerative capacity as compared to adult tissue-derived MSC including peripheral blood (PB-MSC), bone marrow (BM-MSC), or adipose tissue (AD-MSC ( termed AT-MSC or ASC)) [3,4]

Methods
Findings
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call